Disclaimer
We’re actively expanding Guideline Genius to cover the full UKMLA content map. You may notice some conditions not uploaded yet, or articles that only include diagnosis and management for now. For updates, follow us on Instagram @guidelinegenius.
We openly welcome any feedback or suggestions through the anonymous feedback box at the bottom of every article and we’ll do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

Total Live Articles: 326

Urinary Retention

NICE CKS LUTS in men. Last revised: Jun 2025.

NICE BNF Treatment summaries. Urinary retention.

NICE Clinical guideline [CG97] Lower urinary tract symptoms in men: management. 1.7 Treating urinary retention. Last updated: Jun 2015.

Acute Urinary Retention

Definition

Acute urinary retention is defined as the abrupt development of:

  • Inability to pass urine, and
  • painful / palpable / percussible bladder

 

Acute on chronic urinary retention refers to the development of acute urinary retention in a person who has previously had chronic urinary retention.

Aetiology

Obstructive causes
  • BPH – most common
  • Constipation
  • Prostate / bladder cancer
  • Urethral stricture (e.g. from recurrent catheterisation, cytoscopy, recurrent STIs or urethritis)
  • Pelvic organ prolapse (→ compress the urethra / bladder outlet)
  • Stones / blood clots
  • Spinal cord injuries and neurological disorders
Infection
  • UTIs
  • STIs
  • Prostatitis
Trauma Bulbar urethral rupture classically causes acute urinary retention

  • Classically caused by a straddle injury (e.g. bicycle crossbar, fence, beam)
  • Triad of acute urinary retentionblood at urethral meatus + butterfly perineal haematoma (due to urine extravasation)
Medications
  • Drugs with anti-cholinergic property
    • Antimuscarinic (e.g. oxybutynin)
    • Antihistamines
    • TCA (e.g. amptripytline)
  • Opioids
  • Sympathomimetics (e.g. pseudoephedrine, midodrine, noradrenaline and adrenaline)
  • Sedatives / CNS depressants (e.g. benzodiazepines, Z drugs) (↓ awareness and voiding reflex)

Clinical Features

Feature Acute urinary retention Chronic urinary retention
Onset Sudden Gradual
Pain Severe suprapubic pain (patient would be restless and distressed) Usually painless (patient is usually unbothered)
Ability to void Unable to pass urine at all May void small amounts or even overflow incontinence
Bladder Tender Non-tender
Palpable and dullness to percussion

It is important to perform a DRE to evaluate for prostatic conditions (esp. BPH).

An important cause of acute urinary retention is cauda equina syndrome. Always check for other cauda equina syndrome red flags:

  • Bilateral sciatica
  • Saddle paraesthesia / anaesthesia
  • Faecal problems (loss of sensation of rectal fullness)
  • Erectile dysfunction / sexual function
  • Loss of anal tone

Cauda equina syndrome may cause urinary incontinence, but this is typically a late finding. It initially presents with urinary retention, which can subsequently lead to secondary overflow urinary incontinence.

Investigation and Diagnosis

Confirmatory test: bladder scan [Ref1][Ref2]

  • A post-void residual volume >200–400 mL supports urinary retention
  • Note: There is no universally agreed threshold, and cut-offs may vary between guidelines and clinical contexts. The key diagnostic point for acute urinary retention is the inability to pass urine AND a distended bladder confirmed by imaging or physical examination
  • A post-void residual volume <100 mL is typically considered normal

 

Other initial tests:

  • Urinalysis and urine MC&S to exclude UTI
  • Renal function to check for AKI

 

Urodynamic testing is essential when initial evaluation is inconclusive or when neurologic or functional etiologies are suspected, as it distinguishes detrusor underactivity from bladder outlet obstruction. [Ref]

Management

Immediate management: urethral catheterisation

  • Only attempt suprapubic catheterisation if urethral catheterisation has failed or is contraindicated (e.g. urethral trauma)

 

Subsequent management:

  • Usually, a trial without catheter (TWOC) is attempted 1-3 days after initial catheterisation
  • Offer an alpha blocker (e.g. alfuzosin, doxazosin, tamsulosin) for at least 2 days before removing the catheter

Information on types of urinary catheterisation

By route:

Type Key points Typical uses
Urethral catheterisation Passed via the urethra into the bladder 1st line for acute urinary retention
Suprapubic catheterisation Inserted directly into the bladder through the abdominal wall Failed / contraindicated urethral catheter (e.g. urethral trauma, stricture)

By catheter type:

Catheter type Key feature When used
1-way (straight / Nelaton) No balloon Intermittent catheterisation, single drainage
2-way Foley Drainage lumen + balloon Most common indwelling catheter
3-way Foley Extra irrigation channel Used for bladder irrigation (e.g. haematuria with clots)

Chronic Urinary Retention

Definition

Chronic urinary retention is defined as a gradual (over months or years) development of the inability to empty the bladder completely

Aetiology

Chronic urinary retention is typically caused by long-standing pathologies:

  • BPH – most common
  • Neurogenic bladder (e.g. diabetic autonomic neuropathy, spinal disease)
  • Urethral stricture (e.g. from recurrent catheterisation, cystoscopy, recurrent STIs or urethritis)
  • Pelvic organ prolapse (→ compress the urethra / bladder outlet)

Clinical Features

Feature Acute urinary retention Chronic urinary retention
Onset Sudden Gradual
Pain Severe suprapubic pain (patient would be restless and distressed) Usually painless (patient is usually unbothered)
Ability to void Unable to pass urine at all May void small amounts or even overflow incontinence
Bladder Tender Non-tender
Palpable and dullness to percussion

Diagnosis

Diagnostic criteria varies:

  • NICE: post-void residual volume >1L OR the presence of a distended or palpable bladder
  • American Urological Association: post-void residual volume >300 mL on 2 separate occasions AND persisting for at least 6 months [Ref]

 

Investigations:

  • Serum creatinine to assess renal function
  • Consider imaging of the upper urinary tract
  • Urodynamic testing is essential when initial evaluation is inconclusive or when neurologic or functional etiologies are suspected, as it distinguishes detrusor underactivity from bladder outlet obstruction [Ref]

Management

  • 1st line: intermittent bladder catheterisation
  • 2nd line: indwelling urethral / suprapubic catheter
  • 3rd line: surgery (urostomy)

Active surveillance with post-void residual volume measurement, upper renal tract imaging and serum creatinine testing can be offered to those with non-bothersome LUTS secondary to chronic urinary retention

However, note that the presence of impaired renal function or hydronephrosis secondary to chronic urinary retention is an indication for intervention (i.e. catheterisation)

Whenever feasible, intermittent catheterisation is preferred over an indwelling catheter, due to lower infection risk (catheter-associated UTI) and better preservation of bladder function.

References

Share Your Feedback Below

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD